Tag: Veliparib

Can we improve total neoadjuvant therapy for rectal cancer?

Presented By
Dr Thomas George, University of Florida, FL, USA
Trial
Phase 2, NRG-GI002
Conference
ASCO GI 2023
Type
Peer-reviewed article

17 March 2023 08:36

BrighTNess data may change guidelines

Presented By
Prof. Sibylle Loibl, German Breast Group, Germany
Trial
Phase 3, BrighTNess
Conference
ESMO 2021
Type
Peer-reviewed article

19 November 2021 09:49

Effect of veliparib with or without cisplatin in breast cancer: results of SWOG S1416

Presented By
Dr Priyanka Sharma, University of Kansas Medical Center, USA
Trial
Phase 2, SWOG 1416
Conference
ASCO 2020
Type
Peer-reviewed article

8 September 2020 09:30

Combination of PARP inhibition plus chemotherapy in ovarian cancer

Presented By
Robert Coleman, University of Texas, MD Anderson Cancer Center, Houston, USA
Trial
Phase 3, VELIA
Conference
ESMO 2019
Type
Peer-reviewed article

26 November 2019 22:26

Veliparib-chemo combo prolongs survival without disease progression in some advanced breast cancer patients

Presented By
Veronique Diéras, Centre Eugène Marquis, Rennes, France
Trial
Phase 3, BROCADE 3
Conference
ESMO 2019
Type
Peer-reviewed article

26 November 2019 14:04
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com